
30/07/2025
🧪✨ Hope for Safer TB Treatment?
Two new oxazolidinones — sutezolid and delpazolid — show promising results as safer alternatives to linezolid in treating drug-resistant tuberculosis.
📍 Published in The Lancet Infectious Diseases (July 8, 2025)
🧫 Phase 2b trials across South Africa & Tanzania reveal:
🔹 High efficacy
🔹 Minimal side effects
🔹 No cases of nerve damage or anemia
🔹 Potential for broader use in HIV+ patients